The Federal Trade Commission (FTC) has once again taken aim at companies for peddling edible cannabis products that closely mimic popular children's snacks. These products, containing active ingredients from marijuana, are being sold in packaging that appears unsettlingly similar to those of treats like Froot Loops and Chips Ahoy! chocolate chip cookies. "Companies that market and sell edible THC products that are easily mistaken for snacks and candy are not only acting illegally, but they are also putting the health of young children at risk," said Samuel Levine, director of the FTC's Bureau of Consumer Protection, in a statement obtained by ABC Action News. Levine warned these companies that prioritizing profits before children's safety could lead to serious legal consequences.
In concordance, the US Food and Drug Administration (FDA) has joined the chorus of concern alongside the FTC by issuing warnings to five companies this Tuesday. They've taken issue specifically with the sale of copycat edibles containing delta-8 THC – a psychoactive cannabinoid that could easily be mistaken for ordinary snacks by children or unintended consumers, bringing accidental ingestion or overconsumption risks. Dr. Namandjé Bumpus, FDA principal deputy commissioner, highlighted an inadequate or confusing labeling problem that may cause individuals to unwittingly consume these products, as per the details shared by CNN.
Response to these federal warnings has been varied. Earthly Hemps, one of the companies targeted by the letters, has responded by stating that it hasn't sold products like the Dr. Blaze THC Delta-8 Slushers, Doweedos Delta-8 Chips, or Delta-8 Weedos this year. However, the other companies implicated have yet to make their stances known or responded to requests for comment. The FDA has afforded these companies 15 working days to respond with measures they plan to take to rectify the violations. Should the companies fail to comply, the FDA has alluded to possible legal action to address these infringements.
As the regulatory agencies bolster their stance against these deceptive marketing practices, the implications for the cannabis industry could be significant. Not only is the safety of children a paramount concern, but the integrity of the legal cannabis market is also at stake. Companies must tread carefully to ensure that their production and marketing practices align with the regulatory expectations set to protect consumers, especially the youngest and most vulnerable, claimed an FDA statement released by News 5 Cleveland.
